Kintara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTRA and other ETFs, options, and stocks.About KTRA
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001.
CEORobert E. Hoffman
CEORobert E. Hoffman
Employees17
Employees17
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2009
Founded2009
Employees17
Employees17
KTRA Key Statistics
Market cap8.29M
Market cap8.29M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume8.59M
Average volume8.59M
High today$0.16
High today$0.16
Low today$0.1489
Low today$0.1489
Open price$0.16
Open price$0.16
Volume1.27M
Volume1.27M
52 Week high$5.60
52 Week high$5.60
52 Week low$0.081
52 Week low$0.081